Artray (ASX:AYA): Positive customer feedback with scan volumes growing 200%/mth; SAPPHIRE study to kick off in July; Appoints former Pro Medicus CFO as new CFO
Tanner has nice things to say Three visiting senior Tanner Health executives joined Artrya's 3Q26 investor call from Melbourne, giving investors a...
123 Views
Artrya (ASX:AYA): 3Q26 cash flow
Strong cash position: Artrya reported its 3Q26 cash results. With commercialisation only really starting during the quarter, income from customers...
177 Views
Artrya (ASX:AYA): 2Q26 results inline; $76.5 million in cash; SAPPHIRE progressing
Artrya reported its quarterly results, which were broadly in line with expectations. Including the $30 million term deposit, AYA has $76.5 million...
324 Views
Artrya (AYA.ASX): HCA Midwest Health joins SAPPHIRE study - approaching 400,000 annual scan target
Artrya announced that HCA Midwest Health has agreed to “in-principle participation” in the SAPPHIRE study. HCA Midwest Health is one of 15...
300 Views
Artrya (ASX:AYA): Valuation lifted to $6.62; ASX All Ords inclusion expected in March
Following the events at the end of 2025 (outlined below), we’ve revised our earnings forecasts, resulting in a valuation increase to $6.62 per...
183 Views